Skip to main content
SpringerLink
Log in

Miscellaneous Manifestations of Behçet Syndrome

  • Chapter
  • First Online:
Behçet Syndrome

  • 668 Accesses

Abstract

Behçet syndrome (BS) may rarely present with rapidly progressive hearing loss, epididymitis, or orchitis. Fever can occur in BS with neurologic, vascular, or arthritic involvement, but is not a typical finding in their absence. Data for a direct association of BS with malignancy remain difficult to interpret, but several, especially hematologic malignancies and hematinic deficiencies can mimic BS. There is general consensus that manifestations such as hearing loss and epididymitis are part of the BS disease spectrum, but there remains controversy regarding others, such as renal disease. Within those areas of controversy, it is debatable whether a proposed manifestation represents a true association, is part of the BS disease spectrum, or is an independent primary disease mimicking BS. Thorough familiarity with the clinical phenotypes of BS, including its rarer manifestations, is a prerequisite for the successful evaluation of patients with suspected BS, especially if their presentation includes manifestations that lie at the far ends or outside of the recognized Behçet disease spectrum.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Zhou Q, Wang H, Schwartz DM, Stoffels M, Park YH, Zhang Y, et al. Loss-of-function mutations in TNFAIP3 leading to A20 haploinsufficiency cause an early-onset autoinflammatory disease. Nat Genet. 2016;48(1):67–73.

    Article  CAS  PubMed  Google Scholar 

  2. Aeschlimann FA, Batu ED, Canna SW, Go E, Gul A, Hoffmann P, et al. A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease. Ann Rheum Dis. 2018;77(5):728–35.

    Article  CAS  PubMed  Google Scholar 

  3. Kadowaki T, Ohnishi H, Kawamoto N, Hori T, Nishimura K, Kobayashi C, et al. Haploinsufficiency of A20 causes autoinflammatory and autoimmune disorders. J Allergy Clin Immunol. 2018;141(4):1485–8 e11.

    Article  CAS  PubMed  Google Scholar 

  4. Seyahi E, Karaaslan H, Ugurlu S, Yazici H. Fever in Behçet’s syndrome. Clin Exp Rheumatol. 2013;31(3 Suppl 77):64–7.

    PubMed  Google Scholar 

  5. Aeschlimann FA, Batu ED, Canna SW, Go E, Hoffmann P, Leavis HL, Gül A, et al. A20 haploinsufficiency (HA20): clinical phenotypes and disease course of patients with a newly recognised NF-kB-mediated autoinflammatory disease. Ann Rheum Dis. 2018;77:728–35.

    Article  CAS  PubMed  Google Scholar 

  6. Esatoglu SN, Hatemi G, Salihoglu A, Hatemi I, Soysal T, Celik AF. A reappraisal of the association between Behçet’s disease, myelodysplastic syndrome and the presence of trisomy 8: a systematic literature review. Clin Exp Rheumatol. 2015;33(6 Suppl 94):S145–51.

    PubMed  Google Scholar 

  7. Lee KY, Kim DY, Chang JY, Bang D. Two cases of acute leukopenia induced by colchicine with concurrent immunosuppressants use in Behcet’s disease. Yonsei Med J. 2008;49(1):171–3.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Rosenthal NS, Farhi DC. Myelodysplastic syndromes and acute myeloid leukemia in connective tissue disease after single-agent chemotherapy. Am J Clin Pathol. 1996;106(5):676–9.

    Article  CAS  PubMed  Google Scholar 

  9. Demiroglu H, Dundar S. Behcet’s disease and neutropenia. Int J Dermatol. 1997;36(7):557–9.

    Article  CAS  PubMed  Google Scholar 

  10. Rogers RS. Recurrent aphthous stomatitis: clinical characteristics and associated systemic disorders. Semin Cutan Med Surg. 1997;16(4):278–83.

    Article  PubMed  Google Scholar 

  11. Leiferman KM, O’Duffy JD, Perry HO, Greipp PR, Giuliani ER, Gleich GJ. Recurrent incapacitating mucosal ulcerations. A prodrome of the hypereosinophilic syndrome. JAMA. 1982;247(7):1018–20.

    Article  CAS  PubMed  Google Scholar 

  12. Budak-Alpdogan T, Demircay Z, Alpdogan O, et al. Behçet’s disease in patients with chronic myelogenous leukemia: possible role of interferon-alpha treatment in the occurrence of Behçet’s symptoms. Ann Hematol. 1997;74(1):45–8.

    Article  CAS  PubMed  Google Scholar 

  13. Segawa F, Shimizu Y, Saito E, Kinoshita M. Behçet’s disease induced by interferon therapy for chronic myelogenous leukemia. J Rheumatol. 1995;22(6):1183–4.

    CAS  PubMed  Google Scholar 

  14. Budak-Alpdogan T, Demirçay AO, Direskeneli H, Ergun T, Oztürk A, et al. Skin hyperreactivity of Behçet’s patients (pathergy reaction) is also positive in interferon alpha-treated chronic myeloid leukaemia patients, indicating similarly altered neutrophil functions in both disorders. Br J Rheumatol. 1998;37(11):1148–51.

    Article  CAS  PubMed  Google Scholar 

  15. Karincaoglu Y, Kaya E, Esrefoglu M, Aydogdu I. Development of large genital ulcer due to hydroxyurea treatment in a patient with chronic myeloid leukemia and Behcet’s disease. Leuk Lymphoma. 2003;44(6):1063–5.

    Article  CAS  PubMed  Google Scholar 

  16. Vaiopoulos G, Terpos E, Viniou N, Nodaros K, Rombos J, Loukopoulos D. Behcet’s disease in a patient with chronic myelogenous leukemia under hydroxyurea treatment: a case report and review of the literature. Am J Hematol. 2001;66(1):57–8.

    Article  CAS  PubMed  Google Scholar 

  17. Cakmak SK, Gül U, Kiliç A, Gönül M, Soylu S, Demirel O. Behçet’s disease associated with chronic myelogenous leukemia and chronic graft-vs-host disease. Leuk Lymphoma. 2006;47(12):2674–5.

    Article  PubMed  Google Scholar 

  18. Barreyro L, Chlon TM, Starczynowski DT. Chronic immune response dysregulation in MDS pathogenesis. Blood. 2018;132(15):1553–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Gangat N, Patnaik MM, Tefferi A. Myelodysplastic syndromes: contemporary review and how we treat. Am J Hematol. 2016;91(1):76–89.

    Article  CAS  PubMed  Google Scholar 

  20. Ivy KS, Brent Ferrell P Jr. Disordered immune regulation and its therapeutic targeting in myelodysplastic syndromes. Curr Hematol Malig Rep. 2018;13(4):244–55.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Sperling AS, Gibson CJ, Ebert BL. The genetics of myelodysplastic syndrome: from clonal haematopoiesis to secondary leukaemia. Nat Rev Cancer. 2017;17(1):5–19.

    Article  CAS  PubMed  Google Scholar 

  22. Wang C, Yang Y, Gao S, Chen J, Yu J, Zhang H, et al. Immune dysregulation in myelodysplastic syndrome: clinical features, pathogenesis and therapeutic strategies. Crit Rev Oncol Hematol. 2018;122:123–32.

    Article  PubMed  Google Scholar 

  23. Braun T, Fenaux P. Myelodysplastic Syndromes (MDS) and autoimmune disorders (AD): cause or consequence? Best Pract Res Clin Haematol. 2013;26(4):327–36.

    Article  CAS  PubMed  Google Scholar 

  24. Shimanovsky A, Alvarez Argote J, Murali S, Dasanu CA. Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance. BBA Clin. 2016;6:12–8.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Mekinian A, Grignano E, Braun T, Decaux O, Liozon E, Costedoat-Chalumeau N, et al. Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study. Rheumatology (Oxford). 2016;55(2):291–300.

    Article  CAS  Google Scholar 

  26. Komrokji RS, Kulasekararaj A, Al Ali NH, Kordasti S, Bart-Smith E, Craig BM, et al. Autoimmune diseases and myelodysplastic syndromes. Am J Hematol. 2016;91(5):E280–3.

    Article  PubMed  Google Scholar 

  27. Shen Y, Ma HF, Luo D, Cai JF, Zou J, Guan JL. High incidence of gastrointestinal ulceration and cytogenetic aberration of trisomy 8 as typical features of Behcet’s disease associated with myelodysplastic syndrome: a series of 16 consecutive Chinese patients from the Shanghai Behcet’s disease database and comparison with the literature. Biomed Res Int. 2018;2018:8535091.

    PubMed  PubMed Central  Google Scholar 

  28. Tada Y, Koarada S, Haruta Y, Mitamura M, Ohta A, Nagasawa K. The association of Behçet’s disease with myelodysplastic syndrome in Japan: a review of the literature. Clin Exp Rheumatol. 2006;24(5 Suppl 42):S115–9.

    CAS  PubMed  Google Scholar 

  29. Eder L, Rozenbaum M, Boulman N, Aayubkhanov E, Wolfovitz E, Zisman D, et al. Behçet’s disease, myelodysplastic syndrome, trisomy 8, gastroenterological involvement--an association. Clin Exp Rheumatol. 2005;23(4 Suppl 38):S91–5.

    CAS  PubMed  Google Scholar 

  30. Tascilar K, Melikoglu M, Ugurlu S, Sut N, Caglar E, Yazici H. Vascular involvement in Behcet’s syndrome: a retrospective analysis of associations and the time course. Rheumatology (Oxford). 2014;53(11):2018–22.

    Article  CAS  Google Scholar 

  31. Wang S, Broder N, Marchetta P, Nowatzky J. Myelodysplastic syndrome presenting as a Behcet’s-like disease with aortitis. BMJ Case Rep. 2018;2018.

    Google Scholar 

  32. Ahn JK, Cha HS, Koh EM, Kim SH, Kim YG, Lee CK, et al. Behcet’s disease associated with bone marrow failure in Korean patients: clinical characteristics and the association of intestinal ulceration and trisomy 8. Rheumatology (Oxford). 2008;47(8):1228–30.

    Article  CAS  Google Scholar 

  33. Fine LA, Hoffman LD, Hoffman MD. Aphthous ulcerations associated with trisomy 8-positive myelodysplastic syndrome. J Am Acad Dermatol. 2007;57(2 Suppl):S38–41.

    Article  PubMed  Google Scholar 

  34. Lin YC, Liang TH, Chang HN, Lin JS, Lin HY. Behcet disease associated with myelodysplastic syndrome. J Clin Rheumatol. 2008;14(3):169–74.

    Article  PubMed  Google Scholar 

  35. Kimura S, Kuroda J, Akaogi T, Hayashi H, Kobayashi Y, Kondo M. Trisomy 8 involved in myelodysplastic syndromes as a risk factor for intestinal ulcers and thrombosis--Behçet’s syndrome. Leuk Lymphoma. 2001;42(1–2):115–21.

    Article  CAS  PubMed  Google Scholar 

  36. Toyonaga T, Nakase H, Matsuura M, Minami N, Yamada S, Honzawa Y, et al. Refractoriness of intestinal Behçet’s disease with myelodysplastic syndrome involving trisomy 8 to medical therapies - our case experience and review of the literature. Digestion. 2013;88(4):217–21.

    Article  PubMed  Google Scholar 

  37. Sloand EM, Wu CO, Greenberg P, Young N, Barrett J. Factors affecting response and survival in patients with myelodysplasia treated with immunosuppressive therapy. J Clin Oncol. 2008;26(15):2505–11.

    Article  PubMed  Google Scholar 

  38. Becker K, Fitzgerald O, Green AJ, Keogan M, Newbury-Ecob R, Greenhalgh L, et al. Constitutional trisomy 8 and Behçet syndrome. Am J Med Genet A. 2009;149A(5):982–6.

    Article  PubMed  Google Scholar 

  39. Kawabata H, Sawaki T, Kawanami T, Shimoyama K, Karasawa H, Fukushima T, et al. Myelodysplastic syndrome complicated with inflammatory intestinal ulcers: significance of trisomy 8. Intern Med. 2006;45(22):1309–14.

    Article  PubMed  Google Scholar 

  40. Ohno E, Ohtsuka E, Watanabe K, Kohno T, Takeoka K, Saburi Y, et al. Behçet’s disease associated with myelodysplastic syndromes. A case report and a review of the literature. Cancer. 1997;79(2):262–8.

    Article  CAS  PubMed  Google Scholar 

  41. Giannouli S, Voulgarelis M, Zintzaras E, Tzioufas AG, Moutsopoulos HM. Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study. Rheumatology (Oxford). 2004;43(5):626–32.

    Article  CAS  Google Scholar 

  42. Lee SJ, Park JK, Lee EY, Joo SH, Jung KC, Lee EB, et al. Certain autoimmune manifestations are associated with distinctive karyotypes and outcomes in patients with myelodysplastic syndrome: a retrospective Cohort Study. Medicine. 2016;95(13):e3091.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Nonami A, Takenaka K, Sumida C, Aizawa K, Kamezaki K, Miyamoto T, et al. Successful treatment of myelodysplastic syndrome (MDS)-related intestinal Behçet’s disease by up-front cord blood transplantation. Intern Med. 2007;46(20):1753–6.

    Article  PubMed  Google Scholar 

  44. Tomonari A, Tojo A, Takahashi T, Iseki T, Ooi J, Takahashi S, et al. Resolution of Behçet’s disease after HLA-mismatched unrelated cord blood transplantation for myelodysplastic syndrome. Ann Hematol. 2004;83(7):464–6.

    Article  PubMed  Google Scholar 

  45. Yamato K. Successful cord blood stem cell transplantation for myelodysplastic syndrome with Behcet disease. Int J Hematol. 2003;77(1):82–5.

    Article  PubMed  Google Scholar 

  46. Bangerter M, Griesshammer MV, Tirpitz C, Krauter J, Heil G, Hafner M, et al. Myelodysplastic syndrome with monosomy 7 after immunosuppressive therapy in Behçet’s disease. Scand J Rheumatol. 1999;28(2):117–9.

    Article  CAS  PubMed  Google Scholar 

  47. Michels SD, McKenna RW, Arthur DC, Brunning RD. Therapy-related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 cases. Blood. 1985;65(6):1364–72.

    Article  CAS  PubMed  Google Scholar 

  48. Fraison J-B, Mekinian A, Grignano E, Kahn J-E, Arlet J-B, Decaux O, et al. Efficacy of Azacitidine in autoimmune and inflammatory disorders associated with myelodysplastic syndromes and chronic myelomonocytic leukemia. Leuk Res. 2016;43:13–7.

    Article  CAS  PubMed  Google Scholar 

  49. Grignano E, Jachiet V, Fenaux P, Ades L, Fain O, Mekinian A. Autoimmune manifestations associated with myelodysplastic syndromes. Ann Hematol. 2018;97(11):2015–23.

    Article  CAS  PubMed  Google Scholar 

  50. Fenaux P, Mufti GJ, Hellstrom-Lindberg E, Santini V, Finelli C, Giagounidis A, et al. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study. Lancet Oncol. 2009;10(3):223–32.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  51. Costa R, Abdulhaq H, Haq B, Shadduck RK, Latsko J, Zenati M, et al. Activity of azacitidine in chronic myelomonocytic leukemia. Cancer. 2011;117(12):2690–6.

    Article  CAS  PubMed  Google Scholar 

  52. Fianchi L, Criscuolo M, Breccia M, Maurillo L, Salvi F, Musto P, et al. High rate of remissions in chronic myelomonocytic leukemia treated with 5-azacytidine: results of an Italian retrospective study. Leuk Lymphoma. 2013;54(3):658–61.

    Article  CAS  PubMed  Google Scholar 

  53. Kaklamani VG, Tzonou A, Kaklamanis PG. Behçet’s disease associated with malignancies. Report of two cases and review of the literature. Clin Exp Rheumatol. 2005;23(4 Suppl 38):S35–41.

    CAS  PubMed  Google Scholar 

  54. Ahn JK, Oh JM, Lee J, Koh E-M, Cha H-S. Behcet’s disease associated with malignancy in Korea: a single center experience. Rheumatol Int. 2010;30(6):831–5.

    Article  PubMed  Google Scholar 

  55. Lin Y, Li G, Zheng W, Tian X, Zhang F. Behcet’s disease associated with malignancy: a report of 41 Chinese cases. Int J Rheum Dis. 2014;17(4):459–65.

    Article  PubMed  Google Scholar 

  56. Na SY, Shin J, Lee E-S. Morbidity of solid cancer in Behςet’s disease: analysis of 11 cases in a series of 506 patients. Yonsei Med J. 2013;54(4):895–901.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Jung YS, Han M, Kim DY, Cheon JH, Park S. Cancer risk in Korean patients with Behcet’s disease: a nationwide population-based study. PLoS One. 2017;12(12):e0190182.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  58. Wang L-H, Wang W-M, Hsu S-M, Lin S-H, Shieh C-C. Risk of overall and site-specific cancers in Behçet disease: a nationwide population-based study in Taiwan. J Rheumatol. 2015;42(5):879–84.

    Article  CAS  PubMed  Google Scholar 

  59. Calabrese LH, Calabrese C, Cappelli LC. Rheumatic immune-related adverse events from cancer immunotherapy. Nat Rev Rheumatol. 2018;14(10):569–79.

    Article  PubMed  Google Scholar 

  60. Postow MA, Sidlow R, Hellmann MD. Immune-related adverse events associated with immune checkpoint blockade. N Engl J Med. 2018;378(2):158–68.

    Article  CAS  PubMed  Google Scholar 

  61. Dalvin LA, Shields CL, Orloff M, Sato T, Shields JA. CHECKPOINT INHIBITOR IMMUNE THERAPY: systemic indications and ophthalmic side effects. Retina. 2018;38(6):1063–78.

    Article  CAS  PubMed  Google Scholar 

  62. Sun MM, Levinson RD, Filipowicz A, Anesi S, Kaplan H, Wang W, et al. Uveitis in patients treated with CTLA-4 and PD-1 checkpoint blockade inhibition. Ocul Immunol Inflamm. 2019:1–11.

    Google Scholar 

  63. Abdel-Wahab N, Shah M, Lopez-Olivo MA, Suarez-Almazor ME. Use of immune checkpoint inhibitors in the treatment of patients with cancer and preexisting autoimmune disease: a systematic review. Ann Intern Med. 2018;168(2):121–30.

    Article  PubMed  Google Scholar 

  64. Pedersen M, Andersen R, Nørgaard P, Jacobsen S, Thielsen P, Thor Straten P, et al. Successful treatment with Ipilimumab and Interleukin-2 in two patients with metastatic melanoma and systemic autoimmune disease. Cancer Immunol Immunother. 2014;63(12):1341–6.

    Article  CAS  PubMed  Google Scholar 

  65. Sonbay ND, Saka C, Tatlican S, Vuralkan E, Aygener N, Eren C, et al. Audiological evaluation in patients with Behcet’s disease. J Laryngol Otol. 2014;128(8):694–7.

    Article  CAS  PubMed  Google Scholar 

  66. Sota J, Vitale A, Orlando I, Lopalco G, Franceschini R, Fabiani C, et al. Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics. Clin Rheumatol. 2017;36(2):445–9.

    Article  PubMed  Google Scholar 

  67. Adler YD, Jovanovic S, Jivanjee A, Krause L, Zouboulis CC. Adamantiades-Behçet’s disease with inner ear involvement. Clin Exp Rheumatol. 2002;20(4 Suppl 26):S40–2.

    CAS  PubMed  Google Scholar 

  68. Mancini P, Atturo F, Di Mario A, Portanova G, Ralli M, De Virgilio A, et al. Hearing loss in autoimmune disorders: prevalence and therapeutic options. Autoimmun Rev. 2018;17(7):644–52.

    Article  PubMed  Google Scholar 

  69. Marsili M, Marzetti V, Lucantoni M, Lapergola G, Gattorno M, Chiarelli F, et al. Autoimmune sensorineural hearing loss as presenting manifestation of paediatric Behçet disease responding to adalimumab: a case report. Ital J Pediatr. 2016;42(1):81.

    Article  PubMed  PubMed Central  Google Scholar 

  70. Narvaez J, Valverde-Garcia J, Alegre-Sancho JJ, Juanola X, Clavaguera MT, Roig-Escofet D. Sudden cochlear hearing loss in a patient with Behcet’s disease. Rev Rhum Engl Ed. 1998;65(1):63–4.

    CAS  PubMed  Google Scholar 

  71. Gemignani G, Berrettini S, Bruschini P, Sellari-Franceschini S, Fusari P, Piragine F, et al. Hearing and vestibular disturbances in Behçet’s syndrome. Ann Otol Rhinol Laryngol. 1991;100(6):459–63.

    Article  CAS  PubMed  Google Scholar 

  72. Kulahli I, Balci K, Koseoglu E, Yuce I, Cagli S, Senturk M. Audio-vestibular disturbances in Behcet’s patients: report of 62 cases. Hear Res. 2005;203(1–2):28–31.

    Article  PubMed  Google Scholar 

  73. Smith LN. Unilateral sensorineural hearing loss in Behcet’s disease. Am J Otolaryngol. 1994;15(4):286–8.

    Article  CAS  PubMed  Google Scholar 

  74. Choung Y-H, Cho MJ, Park K, Choi SJ, Shin YR, Lee E-S. Audio-vestibular disturbance in patients with Behçet’s disease. Laryngoscope. 2006;116(11):1987–90.

    Article  PubMed  Google Scholar 

  75. Ak E, Harputluoglu U, Oghan F, Baykal B. Behçet’s disease and hearing loss. Auris Nasus Larynx. 2004;31(1):29–33.

    Article  PubMed  Google Scholar 

  76. Bakhshaee M, Mahdi B, Ghasemi MM, Mehdi GM, Hatef MR, Reza HM, et al. Hearing loss in Behçet syndrome. Otolaryngol Head Neck Surg. 2007;137(3):439–42.

    Article  PubMed  Google Scholar 

  77. Bayazit YA, Yilmaz M, Gunduz B, Altinyay S, Kemaloglu YK, Onder M, et al. Distortion product otoacoustic emission findings in Behcet’s disease and rheumatoid arthritis. ORL J Otorhinolaryngol Relat Spec. 2007;69(4):233–8.

    Article  PubMed  Google Scholar 

  78. Dagli M, Eryilmaz A, Tanrikulu S, Aydin A, Gonul M, Gul U, et al. Evaluation of cochlear involvement by distortion product otoacoustic emission in Behçet’s disease. Auris Nasus Larynx. 2008;35(3):333–7.

    Article  PubMed  Google Scholar 

  79. Muluk NB, Birol A. Effects of Behçet’s disease on hearing thresholds and transient evoked otoacoustic emissions. J Otolaryngol. 2007;36(4):220–6.

    Article  PubMed  Google Scholar 

  80. Pollak L, Luxon LM, Haskard DO. Labyrinthine involvement in Behçet’s syndrome. J Laryngol Otol. 2001;115(7):522–9.

    Article  CAS  PubMed  Google Scholar 

  81. Igarashi Y, Watanabe Y, Aso S. A case of Behçet’s disease with otologic symptoms. ORL J Otorhinolaryngol Relat Spec. 1994;56(5):295–8.

    Article  CAS  PubMed  Google Scholar 

  82. Brama I, Fainaru M. Inner ear involvement in Behçet’s disease. Arch Otolaryngol. 1980;106(4):215–7.

    Article  CAS  PubMed  Google Scholar 

  83. Evereklioglu C, Cokkeser Y, Doganay S, Er H, Kizilay A. Audio-vestibular evaluation in patients with Behçet’s syndrome. J Laryngol Otol. 2001;115(9):704–8.

    Article  CAS  PubMed  Google Scholar 

  84. Soylu L, Aydoğan B, Soylu M, Ozsahinoğlu C. Hearing loss in Behçet’s disease. Ann Otol Rhinol Laryngol. 1995;104(11):864–7.

    Article  CAS  PubMed  Google Scholar 

  85. Süslü AE, Polat M, Köybaşi S, Biçer YO, Funda YO, Parlak AH. Inner ear involvement in Behçet’s disease. Auris Nasus Larynx. 2010;37(3):286–90.

    Article  PubMed  Google Scholar 

  86. Mijovic T, Zeitouni A, Colmegna I. Autoimmune sensorineural hearing loss: the otology-rheumatology interface. Rheumatology (Oxford). 2013;52(5):780–9.

    Article  CAS  Google Scholar 

  87. Elidan J, Levi H, Cohen E, BenEzra D. Effect of cyclosporine A on the hearing loss in Behcet’s disease. Ann Otol Rhinol Laryngol. 1991;100(6):464–8.

    Article  CAS  PubMed  Google Scholar 

  88. Quaranta N, Bartoli R, Giagnotti F, Di Cuonzo F, Quaranta A. Cochlear implants in systemic autoimmune vasculitis syndromes. Acta Otolaryngol Suppl. 2002;(548):44–8.

    Article  Google Scholar 

  89. Szilvassy J, Czigner J, Jori J, Toth F, Szilvassy Z, Mieszkowski JM, et al. Cochlear implantation of a Hungarian deaf and blind patient with discharging ears suffering from Behçet’s disease. J Laryngol Otol. 1998;112(2):169–71.

    Article  CAS  PubMed  Google Scholar 

  90. Barna BP, Hughes GB. Autoimmunity and otologic disease: clinical and experimental aspects. Clin Lab Med. 1988;8(2):385–98.

    Article  CAS  PubMed  Google Scholar 

  91. Akpolat T, Dilek M, Aksu K, Keser G, Toprak O, Cirit M, et al. Renal Behçet’s disease: an update. Semin Arthritis Rheum. 2008;38(3):241–8.

    Article  PubMed  Google Scholar 

  92. Cho SB, Kim J, Kang SW, Yoo TH, Zheng Z, Cho S, et al. Renal manifestations in 2007 Korean patients with Behcet’s disease. Yonsei Med J. 2013;54(1):189–96.

    Article  PubMed  Google Scholar 

  93. Kaklamani VG, Nikolopoulou N, Sotsiou F, Billis A, Kaklamanis P. Renal involvement in Adamantiades-Behçet’s disease. Case report and review of the literature. Clin Exp Rheumatol. 2001;19(5 Suppl 24):S55–8.

    CAS  PubMed  Google Scholar 

  94. Rosenthal T, Weiss P, Gafni J. Renal involvement in Behçet’s syndrome. Arch Intern Med. 1978;138(7):1122–4.

    Article  CAS  PubMed  Google Scholar 

  95. Zheng W, Li G, Zhou M, Chen L, Tian X, Zhang F. Renal involvement in Chinese patients with Behcet’s disease: a report of 16 cases. Int J Rheum Dis. 2015;18(8):892–7.

    Article  CAS  PubMed  Google Scholar 

  96. Akpolat T, Akkoyunlu M, Akpolat I, Dilek M, Odabas AR, Ozen S. Renal Behçet’s disease: a cumulative analysis. Semin Arthritis Rheum. 2002;31(5):317–37.

    Article  PubMed  Google Scholar 

  97. Akpolat T, Diri B, Oğuz Y, Yilmaz E, Yavuz M, Dilek M. Behçet’s disease and renal failure. Nephrol Dial Transplant. 2003;18(5):888–91.

    Article  CAS  PubMed  Google Scholar 

  98. Akpolat T, Yilmaz E, Akpolat I, Dilek M, Karagoz F, Balci B, et al. Amyloidosis in Behçet's disease and familial Mediterranean fever. Rheumatology (Oxford). 2002;41(5):592–3.

    Article  CAS  Google Scholar 

  99. Dilsen N, Konice M, Aral O, Erbengi T, Uysal V, Kocak N, et al. Ozdogan et’s disease associated with amyloidosis in Turkey and in the world. Ann Rheum Dis. 1988;47(SRC - BaiduScholar):157–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  100. Melikoglu M, Altiparmak MR, Fresko I, Tunc R, Yurdakul S, Hamuryudan V, et al. A reappraisal of amyloidosis in Behçet’s syndrome. Rheumatology (Oxford). 2001;40(SRC - BaiduScholar):212–5.

    Article  CAS  Google Scholar 

  101. Yurdakul S, Tüzüner N, Yurdakul I, Hamuryudan V, Yazici H. Amyloidosis in Behçet’s syndrome. Arthritis Rheum. 1990;33(10):1586–9.

    Article  CAS  PubMed  Google Scholar 

  102. Chiba M, Inoue Y, Arakawa H, Masamune O, Ohkubo M. Behçet’s disease associated with amyloidosis. Gastroenterol Jpn. 1987;22(4):487–95.

    Article  CAS  PubMed  Google Scholar 

  103. Erten S, Perçınel S, Olmez U, Ensarı A, Düzgün N. Behçet’s disease associated with diarrhea and secondary amyloidosis. Turk J Gastroenterol. 2011;22(1):106–7.

    Article  PubMed  Google Scholar 

  104. Sato S, Yashiro M, Matsuoka N, Kawana S, Asano T, Kobayashi H, et al. Behcet disease associated with gastrointestinal amyloidosis manifested as hematochezia: a case report. Medicine (Baltimore). 2018;97(26):e11153.

    Article  Google Scholar 

  105. Kosemehmetoglu K, Baydar DE. Renal amyloidosis in Behçet’s disease: clinicopathologic features of 8 cases. Int Urol Nephrol. 2013;45(3):785–94.

    Article  PubMed  Google Scholar 

  106. Rosenthal T, Bank H, Aladjem M, David R, Gafni J. Systemic amyloidosis in Behçet’s disease. Ann Intern Med. 1975;83(2):220–3.

    Article  CAS  PubMed  Google Scholar 

  107. Utku U, Dilek M, Akpolat I, Bedir A, Akpolat T. SAA1 alpha/alpha alleles in Behçet’s disease related amyloidosis. Clin Rheumatol. 2007;26(6):927–9.

    Article  PubMed  Google Scholar 

  108. Tasdemir I, Sivri B, Turgan C, Emri S, Yasavul U, Caglar S. The expanding spectrum of a disease. Behçet’s disease associated with amyloidosis. Nephron. 1989;52(2):154–7.

    Article  CAS  PubMed  Google Scholar 

  109. Bilginer Y, Ayaz NA, Ozen S. Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behçet’s disease. Clin Rheumatol. 2010;29(2):209–10.

    Article  PubMed  Google Scholar 

  110. Ilbay A, Erden A, Sari A, Armagan B, Aktas BY, Bolek EC, et al. Successful treatment of amyloid A-type amyloidosis due to Behçet disease with Tocilizumab. J Clin Rheumatol. 2018;25(4):43.

    Article  Google Scholar 

  111. Altiparmak MR, Tanverdi M, Pamuk ON, Tunç R, Hamuryudan V. Glomerulonephritis in Behçet’s disease: report of seven cases and review of the literature. Clin Rheumatol. 2002;21(1):14–8.

    Article  CAS  PubMed  Google Scholar 

  112. Gürler A, Boyvat A, Türsen U. Clinical manifestations of Behçet’s disease: an analysis of 2147 patients. Yonsei Med J. 1997;38(6):423–7.

    Article  PubMed  Google Scholar 

  113. Kavala M, Menteş F, Kocaturk E, Ergin H, Zindanci I, Can B, et al. Microalbuminuria as an early marker of renal involvement in Behcet’s disease: it is associated with neurological involvement and duration of the disease. J Eur Acad Dermatol Venereol. 2010;24(7):840–3.

    Article  CAS  PubMed  Google Scholar 

  114. Finucane P, Doyle CT, Ferriss JB, Molloy M, Murnaghan D. Behçet’s syndrome with myositis and glomerulonephritis. Br J Rheumatol. 1985;24(4):372–5.

    Article  CAS  PubMed  Google Scholar 

  115. Tietjen DP, Moore WJ. Treatment of rapidly progressive glomerulonephritis due to Behçet’s syndrome with intravenous cyclophosphamide. Nephron. 1990;55(1):69–73.

    Article  CAS  PubMed  Google Scholar 

  116. Kim HJ, Kang SW, Park SJ, Kim TH, Kang MS, Kim YH. Fibrillary glomerulonephritis associated with Behçet’s syndrome. Ren Fail. 2012;34(5):637–9.

    Article  CAS  PubMed  Google Scholar 

  117. Donnelly S, Jothy S, Barré P. Crescentic glomerulonephritis in Behçet’s syndrome--results of therapy and review of the literature. Clin Nephrol. 1989;31(4):213–8.

    CAS  PubMed  Google Scholar 

  118. El Ramahi KM, Al Dalaan A, Al Shaikh A, Al Meshari K, Akhtar M. Renal involvement in Behçet’s disease: review of 9 cases. J Rheumatol. 1998;25(11):2254–60.

    PubMed  Google Scholar 

  119. Fukuda T, Hayashi K, Sakamoto I, Mori M. Acute renal infarction caused by Behçet’s disease. Abdom Imaging. 1995;20(3):264–6.

    Article  CAS  PubMed  Google Scholar 

  120. Sudo J, Matsubara T, Iwai H, Ueda Y, Kameda S, Iwata T, et al. IgA nephropathy developed in a patient with Behçet’s disease. Kidney Dial. 1987;22 SRC - BaiduScholar:893–7.

    Google Scholar 

  121. Sugiyama E, Suzuki H, Akagawa N, Yamashita N, Yano S, Iida H, et al. Behçet’s disease associated with IgA nephropathy: report of a case. Nippon Naika Gakkai Zasshi. 1984;73(12):1818–22.

    Article  CAS  PubMed  Google Scholar 

  122. Hamuryudan V, Yurdakul S, Kural AR, Ince U, Yazici H. Diffuse proliferative glomerulonephritis in Behcet’s syndrome. Br J Rheumatol. 1991;30(1):63–4.

    Article  CAS  PubMed  Google Scholar 

  123. Park SJ, Oh JY, Shin JI. Could increased IgA induced by BAFF be the cause of IgA nephropathy development in Behcet’s disease? Comment on: Behcet’s disease and IgA nephropathy (Rheumatol Int. 2012 Jul; 32(7):2227–9). Rheumatol Int. 2014;34(2):283–4.

    Article  PubMed  Google Scholar 

  124. Oygar DD, Morris Y. Behçet’s disease and anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Intern Med. 2016;55(16):2225–8.

    Article  PubMed  Google Scholar 

  125. Leonard D, Cortese C, Wadei HM, Porter Ii IE, Aslam N. Behcet’s syndrome and focal segmental glomerulosclerosis with nephrotic syndrome - successful treatment with etanercept. Clin Nephrol. 2018;89(5):371–5.

    Article  CAS  PubMed  Google Scholar 

  126. Koç Y, Güllü I, Akpek G, Akpolat T, Kansu E, Kiraz S, et al. Vascular involvement in Behçet’s disease. J Rheumatol. 1992;19(3):402–10.

    PubMed  Google Scholar 

  127. Sherif A, Stewart P, Mendes DM. The repetitive vascular catastrophes of Behçet’s disease: a case report with review of the literature. Ann Vasc Surg. 1992;6(1):85–9.

    Article  CAS  PubMed  Google Scholar 

  128. Sueyoshi E, Sakamoto I, Hayashi N, Fukuda T, Matsunaga N, Hayashi K, et al. Ruptured renal artery aneurysm due to Behçet’s disease. Abdom Imaging. 1996;21(2):166–7.

    Article  CAS  PubMed  Google Scholar 

  129. Han K, Siegel R, Pantuck AJ, Gazi MA, Burno DK, Weiss RE. Behcet’s syndrome with left ventricular aneurysm and ruptured renal artery pseudoaneurysm. Urology. 1999;54(1):162.

    Article  CAS  PubMed  Google Scholar 

  130. Chen JY, Tsai YS, Li YH. Multiple arterial aneurysms in a patient with Behcet’s disease. Eur Heart J Cardiovasc Imaging. 2016;17(5):587.

    Article  PubMed  Google Scholar 

  131. Batur A, Dorum M, Yuksekkaya HA, Koc O. Budd-chiari syndrome and renal arterial neurysms due to Behcet disease: a rare association. Pan Afr Med J. 2015;21:84.

    Article  PubMed  PubMed Central  Google Scholar 

  132. Toprak O, Ersoy R, Uzum A, Memis A, Cirit M, Akpolat T. An unusual vascular involvement in a patient with Behcet’s disease: renal artery stenosis. Am J Med Sci. 2007;334(5):396–8.

    Article  PubMed  Google Scholar 

  133. Malik GH, Sirwal IA, Pandit KA. Behcet’s syndrome associated with minimal change glomerulonephritis and renal vein thrombosis. Nephron. 1989;52(1):87–9.

    Article  CAS  PubMed  Google Scholar 

  134. Angotti C, D’Cruz DP, Abbs IC, Hughes GRV. Renal microinfarction in Behçet’s disease. Rheumatology (Oxford). 2003;42(11):1416–7.

    Article  CAS  Google Scholar 

  135. Planer D, Verstandig A, Chajek-Shaul T. Transcatheter embolization of renal artery aneurysm in Behçet’s disease. Vasc Med. 2001;6(2):109–12.

    Article  CAS  PubMed  Google Scholar 

  136. Ali O, Nicholl P, Carruthers D, Geoghegan J, Tiwari A. Multiple aneurysms and a transplanted kidney in Behçet disease. Vasc Endovasc Surg. 2017;51(2):108–10.

    Article  Google Scholar 

  137. Apaydin S, Erek E, Ulkü U, Hamuryudan V, Yazici H, Sariyar M. A successful renal transplantation in Behçet’s syndrome. Ann Rheum Dis. 1999;58(11):719.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  138. Kirkali Z, Yigitbasi O, Sasmaz R. Urological aspects of Behçet’s disease. Br J Urol. 1991;67(6):638–9.

    Article  CAS  PubMed  Google Scholar 

  139. Kanakis MA, Vaiopoulos AG, Vaiopoulos GA, Kaklamanis PG. Epididymo-Orchitis in Bechet’s disease: a review of the wide spectrum of the disease. Acta Med Iran. 2017;55(8):482–5.

    PubMed  Google Scholar 

  140. Sharquie KE, Al-Rawi Z. Epididymo-orchitis in Behçets disease. Br J Rheumatol. 1987;26(6):468–9.

    Article  CAS  PubMed  Google Scholar 

  141. Kaklamani VG, Vaiopoulos G, Markomichelakis N, Kaklamanis P. Recurrent epididymo-orchitis in patients with Behçet’s disease. J Urol. 2000;163(2):487–9.

    Article  CAS  PubMed  Google Scholar 

  142. Callejas-Rubio JL, Ortego N, Díez A, Castro M, De La Higuera J. Recurrent epididymo-orchitis secondary to Behçets disease. J Urol. 1998;160(2):496.

    Article  CAS  PubMed  Google Scholar 

  143. Yilmaz O, Yilmaz S, Kisacik B, Aydogdu M, Bozkurt Y, Erdem H, et al. Varicocele and epididymitis in Behcet disease. J Ultrasound Med. 2011;30(7):909–13.

    Article  PubMed  Google Scholar 

  144. Pannek J, Haupt G. Orchitis due to vasculitis in autoimmune diseases. Scand J Rheumatol. 1997;26(3):151–4.

    Article  CAS  PubMed  Google Scholar 

  145. Eilber KS, Freedland SJ, Rajfer J. Polyarteritis nodosa presenting as hematuria and a testicular mass. J Urol. 2001;166(2):624.

    Article  CAS  PubMed  Google Scholar 

  146. Mayer DF, Matteson EL. Testicular involvement in rheumatoid vasculitis. Clin Exp Rheumatol. 2004;22(6 Suppl 36):S62–4.

    CAS  PubMed  Google Scholar 

  147. Joudi FN, Austin JC, Vogelgesang SA, Jensen CS. Isolated testicular vasculitis presenting as a tumor-like lesion. J Urol. 2004;171(2 Pt 1):799.

    Article  PubMed  Google Scholar 

  148. Yamashita C, Otsuka A, Dainichi T, Kabashima K. Novel MEFV variant Q311H in an incomplete Behçet’s disease patient with recurrent epididymitis. J Eur Acad Dermatol Venereol. 2016;30(11):e173–e4.

    CAS  PubMed  Google Scholar 

  149. Ek L, Hedfors E. Behçet’s disease: a review and a report of 12 cases from Sweden. Acta Derm Venereol. 1993;73(4):251–4.

    CAS  PubMed  Google Scholar 

  150. Zouboulis CC, Kötter I, Djawari D, Kirch W, Kohl PK, Ochsendorf FR, et al. Epidemiological features of Adamantiades-Behçet’s disease in Germany and in Europe. Yonsei Med J. 1997;38(6):411–22.

    Article  CAS  PubMed  Google Scholar 

  151. Fuse H, Ohkawa M, Yamaguchi K, Hirata A, Matsubara F. Cryptococcal prostatitis in a patient with Behçet’s disease treated with fluconazole. Mycopathologia. 1995;130(3):147–50.

    Article  CAS  PubMed  Google Scholar 

  152. Chajek T, Fainaru M. Behçet’s disease. Report of 41 cases and a review of the literature. Medicine. 1975;54(3):179–96.

    Article  CAS  PubMed  Google Scholar 

  153. McDonald GS, Gad-Al-Rab J. Behçet’s disease with endocarditis and the Budd-Chiari syndrome. J Clin Pathol. 1980;33(7):660–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  154. Ates A, Aydintug OT, Duzgun N, Yaman O, Sancak T, Omür ND. Omur et’s disease presenting as deep venous thrombosis and priapism. Clin Exp Rheumatol. 2004;22(1 SRC - BaiduScholar):107–9.

    CAS  PubMed  Google Scholar 

  155. Moalla M, Gabsi M, el Ouakdi M, Zmerli S, Ben Ayed H. Behçet disease and priapism. J Rheumatol. 1990;17(4):570–1.

    CAS  PubMed  Google Scholar 

  156. Beddouche A, Ouaziz H, Zougaghi S, Alaoui A, Dergamoun H, El Sayegh H, et al. Deep dorsal penile vein thrombosis revealing Behcet’s disease. Pan Afr Med J. 2016;24:17.

    PubMed  PubMed Central  Google Scholar 

  157. Erdogru T, Kocak T, Serdaroglu P, Kadioglu AS, Taylan A, et al. Evaluation and therapeutic approaches of voiding and erectile dysfunction in neurological Behçet’s syndrome. Birlik neuroBehet disease with erectile dysfunction and micturition disturbances case report and literature review. Rheumatol Int. 38149152. 2018;162(1 SRC - BaiduScholar):147–53.

    Google Scholar 

  158. Taylan A, Birlik M. Parenchymal neuro-Behçet disease with erectile dysfunction and micturition disturbances: case report and literature review. Rheumatol Int. 2018;38(1):149–52.

    Article  PubMed  Google Scholar 

  159. Kone-Paut I, Yurdakul S, Bahabri SAJ, et al. Clinical features of Behçet’s disease in children: an international collaborative study of 86 cases. 1998;132(4 SRC - BaiduScholar):721–5.

    Google Scholar 

  160. Shaefei N, Shahram F, Davatchi F, et al. Comparison of juvenile with adult Behçet’s disease (A). Arthritis Rheum. 1998;41(S124).

    Google Scholar 

  161. Pektas A, Devrim I, Besbas N, Bilginer Y, Cengiz AB, Ozen S. A child with Behcet’s disease presenting with a spectrum of inflammatory manifestations including epididymoorchitis. Turk J Pediatr. 2008;50(1):78–80.

    PubMed  Google Scholar 

  162. Alizadeh F, Khorrami MH, Izadpanahi MH, Nouri-Mahdavi K, Mohammadi Sichani M. Bladder involvement in Behcet’s disease. Urol J. 2012;9(1):347–50.

    PubMed  Google Scholar 

  163. Lakhanpal S, Tani K, Lie JT, Katoh K, Ishigatsubo Y, Ohokubo T. Pathologic features of Behçet’s syndrome: a review of Japanese autopsy registry data. Hum Pathol. 1985;16(8):790–5.

    Article  CAS  PubMed  Google Scholar 

  164. Dokmeci F, Cengiz BF. Ortac mass in a patient with Behçet’s disease. Obstet Gynecol 881. 1996;87(5 Pt 2 SRC - BaiduScholar).

    Google Scholar 

  165. Cetinel B, Akpinar H, Tüfek I, Uygun N, Solok V, Yazici H. Bladder involvement in Behçet’s syndrome. J Urol. 1999;161(1):52–6.

    Article  CAS  PubMed  Google Scholar 

  166. Monteiro H, Nogueira RH, Akin Y, Yucel SJ, et al. de Carvalho et’s syndrome and vesicovaginal fistula: an unusual complication. An extremely rare manifestation of Behcets disease urethrovaginal fistula. Int Urol Nephrol. 4635961. 2014;153(2 SRC - BaiduScholar):407–8.

    Google Scholar 

  167. Akin Y, Yucel S, Baykara M. An extremely rare manifestation of Behcet’s disease: urethrovaginal fistula. Int Urol Nephrol. 2014;46(2):359–61.

    Article  CAS  PubMed  Google Scholar 

  168. Aoki T, Tanaka T, Akifuji Y, Ueki J, Nakamura I, Nemoto R, et al. Beneficial effects of interferon-alpha in a case with Behçet’s disease. Intern Med. 2000;39(8):667–9.

    Article  CAS  PubMed  Google Scholar 

  169. Cetinel B, Obek C, Solok V, Yaycioglu O, Yazici H. Urologic screening for men with Behçet’s syndrome. Urology. 1998;52(5):863–5.

    Article  CAS  PubMed  Google Scholar 

  170. Saito M, Miyagawa I. Bladder dysfunction due to Behçet’s disease. Urol Int. 2000;65(1):40–2.

    Article  CAS  PubMed  Google Scholar 

  171. Karandreas N, Tsivgoulis G, Zambelis T, Kokotis P, Rapidi A, Petropoulou K, et al. Urinary frequency in a case of Neuro-Behcet disease involving the brainstem - clinical, electrophysiological and urodynamic features. Clin Neurol Neurosurg. 2007;109(9):806–10.

    Article  PubMed  Google Scholar 

  172. Akman-Demir G, Serdaroglu P, Tasçi B. Clinical patterns of neurological involvement in Behçet’s disease: evaluation of 200 patients. The Neuro-Behçet Study Group. Brain. 1999;122(Pt 11):2171–82.

    Article  PubMed  Google Scholar 

  173. Yesilot N, Mutlu M, Gungor O, Baykal B, Serdaroglu P, Akman-Demir G. Clinical characteristics and course of spinal cord involvement in Behçet’s disease. Eur J Neurol. 2007;14(7):729–37.

    Article  CAS  PubMed  Google Scholar 

  174. Szymajda A, Eledrisi MS, Patel R, Chaljub G, Cepeda E, Kaushik P. Diabetes insipidus as a consequence of neurologic involvement in Behcet’s syndrome. Endocr Pract. 2003;9(1):33–5.

    Article  PubMed  Google Scholar 

  175. Jin-No M, Fujii T, Jin-No Y, Kamiya Y, Okada M, Kawaguchi M. Central diabetes insipidus with Behçet’s disease. Intern Med. 1999;38(12):995–9.

    Article  CAS  PubMed  Google Scholar 

  176. Theodorou C, Floratos D, Hatzinicolaou P, Vaiopoulos G. Neurogenic bladder dysfunction due to Behçet’s disease. Int J Urol. 1999;6(8):423–5.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, USA

    Johannes Nowatzky

  2. Department of Internal Medicine, Division of Rheumatology, Cerrahpasa Medical Faculty, Istanbul, Turkey

    İzzet Fresko

Authors
  1. Johannes Nowatzky
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. İzzet Fresko
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Johannes Nowatzky .

Editor information

Editors and Affiliations

  1. School of Medicine, New York University, New York, NY, USA

    Yusuf Yazici

  2. Department of Internal Medicine, Istanbul University, Istanbul, Turkey

    Gulen Hatemi

  3. Department of Rheumatology, Istanbul University, Istanbul, Turkey

    Emire Seyahi

  4. Department of Medicine, Academic Hospital, Istanbul, Turkey

    Hasan Yazici

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Nowatzky, J., Fresko, İ. (2020). Miscellaneous Manifestations of Behçet Syndrome. In: Yazici, Y., Hatemi, G., Seyahi, E., Yazici, H. (eds) Behçet Syndrome. Springer, Cham. https://doi.org/10.1007/978-3-030-24131-5_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-24131-5_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-24130-8

  • Online ISBN: 978-3-030-24131-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation